WO2006087717A3 - Non-immediate effects of therapy - Google Patents
Non-immediate effects of therapy Download PDFInfo
- Publication number
- WO2006087717A3 WO2006087717A3 PCT/IL2006/000204 IL2006000204W WO2006087717A3 WO 2006087717 A3 WO2006087717 A3 WO 2006087717A3 IL 2006000204 W IL2006000204 W IL 2006000204W WO 2006087717 A3 WO2006087717 A3 WO 2006087717A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- therapy
- immediate effects
- patient
- metabolic condition
- target
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
- A61B5/4519—Muscles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37205—Microstimulators, e.g. implantable through a cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
- A61N1/37288—Communication to several implantable medical devices within one patient
Abstract
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06711186.4A EP1868679B1 (en) | 2005-02-17 | 2006-02-16 | Non-immediate effects of therapy |
US11/884,389 US9101765B2 (en) | 1999-03-05 | 2006-02-16 | Non-immediate effects of therapy |
PCT/US2006/017281 WO2006119467A2 (en) | 2005-05-04 | 2006-05-04 | Protein activity modification |
EP06759102.4A EP1898991B1 (en) | 2005-05-04 | 2006-05-04 | Protein activity modification |
US11/919,491 US8548583B2 (en) | 2004-03-10 | 2006-05-04 | Protein activity modification |
US11/802,685 US8352031B2 (en) | 2004-03-10 | 2007-05-24 | Protein activity modification |
US13/970,647 US8977353B2 (en) | 2004-03-10 | 2013-08-20 | Protein activity modification |
US14/641,480 US9440080B2 (en) | 2004-03-10 | 2015-03-09 | Protein activity modification |
US14/821,848 US9821158B2 (en) | 2005-02-17 | 2015-08-10 | Non-immediate effects of therapy |
US15/249,506 US10352948B2 (en) | 2004-03-10 | 2016-08-29 | Protein activity modification |
US16/232,088 US20190137513A1 (en) | 2004-03-10 | 2018-12-26 | Protein activity modification |
US17/524,015 US11779768B2 (en) | 2004-03-10 | 2021-11-11 | Protein activity modification |
US18/377,857 US20240042214A1 (en) | 2004-12-09 | 2023-10-09 | Protein activity modification |
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65405605P | 2005-02-17 | 2005-02-17 | |
US60/654,056 | 2005-02-17 | ||
PCT/IL2005/000316 WO2005087310A2 (en) | 2004-03-18 | 2005-03-18 | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
ILPCT/IL2005/000316 | 2005-03-18 | ||
US67776105P | 2005-05-04 | 2005-05-04 | |
US60/677,761 | 2005-05-04 | ||
US71951705P | 2005-09-22 | 2005-09-22 | |
US71942105P | 2005-09-22 | 2005-09-22 | |
US60/719,421 | 2005-09-22 | ||
US60/719,517 | 2005-09-22 | ||
USPCT/US2005/044557 | 2005-12-09 | ||
PCT/US2005/044557 WO2006073671A1 (en) | 2004-12-09 | 2005-12-09 | Protein activity modification |
Related Parent Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2002/000856 Continuation-In-Part WO2003045493A2 (en) | 1999-03-05 | 2002-10-24 | Sensing of pancreatic electrical activity |
US10/497,126 Continuation-In-Part US20070060812A1 (en) | 2001-11-29 | 2002-10-24 | Sensing of pancreatic electrical activity |
PCT/IL2004/000797 Continuation-In-Part WO2005023081A2 (en) | 1999-03-05 | 2004-09-05 | Blood glucose level control |
PCT/IL2005/000316 Continuation-In-Part WO2005087310A2 (en) | 1999-03-05 | 2005-03-18 | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
PCT/US2005/044557 Continuation-In-Part WO2006073671A1 (en) | 1999-03-05 | 2005-12-09 | Protein activity modification |
Related Child Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/884,389 A-371-Of-International US9101765B2 (en) | 1999-03-05 | 2006-02-16 | Non-immediate effects of therapy |
US11/919,491 Continuation US8548583B2 (en) | 2004-03-10 | 2006-05-04 | Protein activity modification |
PCT/US2006/017281 Continuation WO2006119467A2 (en) | 2004-03-10 | 2006-05-04 | Protein activity modification |
PCT/US2006/017281 Continuation-In-Part WO2006119467A2 (en) | 2004-03-10 | 2006-05-04 | Protein activity modification |
US11/802,685 Continuation US8352031B2 (en) | 2004-03-10 | 2007-05-24 | Protein activity modification |
US14/821,848 Division US9821158B2 (en) | 2005-02-17 | 2015-08-10 | Non-immediate effects of therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006087717A2 WO2006087717A2 (en) | 2006-08-24 |
WO2006087717A3 true WO2006087717A3 (en) | 2006-12-14 |
Family
ID=36916849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2006/000204 WO2006087717A2 (en) | 1999-03-05 | 2006-02-16 | Non-immediate effects of therapy |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1868679B1 (en) |
WO (1) | WO2006087717A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
US8958872B2 (en) | 1996-01-08 | 2015-02-17 | Impulse Dynamics, N.V. | Electrical muscle controller |
US8977353B2 (en) | 2004-03-10 | 2015-03-10 | Impulse Dynamics Nv | Protein activity modification |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US9265930B2 (en) | 1997-07-16 | 2016-02-23 | Metacure Limited | Methods and devices for modifying vascular parameters |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US9339190B2 (en) | 2005-02-17 | 2016-05-17 | Metacure Limited | Charger with data transfer capabilities |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
EP1827571B1 (en) | 2004-12-09 | 2016-09-07 | Impulse Dynamics NV | Protein activity modification |
US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
ATE533403T1 (en) | 2005-03-24 | 2011-12-15 | Metacure Ltd | WIRELESS CABLES FOR GASTROINTESTINAL APPLICATIONS |
US9233075B2 (en) | 2005-08-09 | 2016-01-12 | Metacure Limited | Satiety |
WO2008139463A2 (en) | 2007-05-09 | 2008-11-20 | Metacure Ltd. | Analysis and regulation of food intake |
CA2822079A1 (en) | 2010-12-17 | 2012-06-21 | Neural Diabetes Llc | Method, system and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production |
EP3180069B1 (en) | 2014-08-17 | 2020-05-13 | Nine Continents Medical, Inc. | Miniature implatable neurostimulator system for sciatic nerves and their branches |
WO2023235443A1 (en) * | 2022-06-01 | 2023-12-07 | Dexcom, Inc. | Sensing systems and methods for diagnosing kidney disease |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231988A (en) * | 1991-08-09 | 1993-08-03 | Cyberonics, Inc. | Treatment of endocrine disorders by nerve stimulation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6895278B1 (en) * | 1999-04-14 | 2005-05-17 | Transneuronix, Inc. | Gastric stimulator apparatus and method for use |
-
2006
- 2006-02-16 EP EP06711186.4A patent/EP1868679B1/en not_active Not-in-force
- 2006-02-16 WO PCT/IL2006/000204 patent/WO2006087717A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231988A (en) * | 1991-08-09 | 1993-08-03 | Cyberonics, Inc. | Treatment of endocrine disorders by nerve stimulation |
Non-Patent Citations (1)
Title |
---|
See also references of EP1868679A4 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8958872B2 (en) | 1996-01-08 | 2015-02-17 | Impulse Dynamics, N.V. | Electrical muscle controller |
US9186514B2 (en) | 1996-01-08 | 2015-11-17 | Impulse Dynamics Nv | Electrical muscle controller |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US9265930B2 (en) | 1997-07-16 | 2016-02-23 | Metacure Limited | Methods and devices for modifying vascular parameters |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US8977353B2 (en) | 2004-03-10 | 2015-03-10 | Impulse Dynamics Nv | Protein activity modification |
US9440080B2 (en) | 2004-03-10 | 2016-09-13 | Impulse Dynamics Nv | Protein activity modification |
US9339190B2 (en) | 2005-02-17 | 2016-05-17 | Metacure Limited | Charger with data transfer capabilities |
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
Also Published As
Publication number | Publication date |
---|---|
EP1868679A2 (en) | 2007-12-26 |
WO2006087717A2 (en) | 2006-08-24 |
EP1868679A4 (en) | 2012-10-24 |
EP1868679B1 (en) | 2017-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006087717A3 (en) | Non-immediate effects of therapy | |
EP3150204A3 (en) | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | |
WO2006099610A3 (en) | Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy | |
WO2008127373A3 (en) | Methods and devices for treating tissue | |
WO2009051706A3 (en) | Peptide compounds for treating obesity and insulin resistance | |
WO2006113802A3 (en) | Device for administering electrode stimulation of back and abdominal muscles | |
GB0518219D0 (en) | Improvements in or relating to cryogenic therapeutic treatments | |
WO2008016922A3 (en) | Peri-capsular fibroid treatment | |
WO2004064728A3 (en) | Use of specific tetracycline compounds in therapy | |
WO2006127007A3 (en) | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions | |
WO2007089454A3 (en) | Methods for enhancing skin treatments | |
WO2005096990A3 (en) | Novel modification of medical prostheses | |
WO2007128761A3 (en) | Uses of dpp-iv inhibitors | |
AU2003231011A1 (en) | Independent therapy programs in an implantable medical device | |
WO2010044879A3 (en) | Method and devices for self adjusting phototherapeutic intervention | |
WO2006073671A8 (en) | Protein activity modification | |
WO2009009383A3 (en) | Devices, systems and methods for treating tissues | |
WO2007006012A3 (en) | Methods for reducing pathogens in biological samples | |
WO2005094554A3 (en) | Therapeutic agents, methods, and treatments | |
CY1110182T1 (en) | IDEENONON FOR THE TREATMENT OF MUSCLE DYSTROPHY | |
WO2007028123A3 (en) | Cochlear implant fitting | |
WO2007064900A3 (en) | Treatment of lesions or imperfections in mammalian skin or near-skin tissues or in or near other anatomic surfaces | |
WO2009079451A3 (en) | Compositions and methods of promoting wound healing | |
WO2009031606A1 (en) | Therapeutic and prophylactic agents for arthritis | |
WO2007100728A3 (en) | Mannose derivatives for killing tumor cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11802685 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11884389 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2006711186 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006711186 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11802685 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2006711186 Country of ref document: EP |